Diverse psychotropic substances detected in drug and drug administration equipment samples submitted to drug checking services in Toronto, Ontario, Canada, October 2019-April 2020.
Kristy M ScarfoneNazlee MaghsoudiKaren McDonaldCristiana StefanDaniel R BeriaultErnest WongMark EvertShaun HopkinsPeter LeslieTara Marie WatsonDaniel Werbnull nullPublished in: Harm reduction journal (2022)
Toronto's DCS identified a range of high-potency opioids with stimulants, benzodiazepine-type drugs, and a synthetic cannabinoid, AMB-FUBINACA. This information can inform a range of evidence-informed overdose prevention efforts.